National
Anti-gay groups speak out in Prop 8, DOMA briefs
‘Gov’t should not put its seal of approval on that unholy union’
The Family Research Council, headed by Tony Perkins, filed briefs in the Prop 8 and DOMA cases. (Blade file photo by Michael Key)
Anti-gay groups — ranging from the Family Research Council to the Westboro Baptish Church — filed friend-of-the-court briefs before the Supreme Court this week asking justices to uphold California’s Proposition 8 and the Defense of Marriage Act.
The briefs filed on Tuesday assert the same arguments seen repeatedly in opposition to a fundamental right to same-sex marriage, such as the inability of gay couples to procreate and the argument that being gay isn’t an immutable characteristic.
The Family Research Council, one the more prominent anti-gay groups opposed to same-sex marriage, filed briefs in both the Prop 8 and DOMA cases. In the Prop 8 brief, the group argues that the California ban on same-sex marriage isn’t discriminatory, among other reasons, because it enables any person to marry — so long as the other person is of the opposite sex.
“Proposition 8 treats men and women the same,” the brief states. “Both may marry someone of the opposite sex; neither may marry someone of the same sex.”
As Right Wing Watch points out, Family Research Council makes arguments on the political power of gays and lesbians that are contradictory. In the Prop 8 brief, the group notes that 30 states have amendments defining marriage as one man, one woman while arguing that “there is no ‘emerging awareness’ that the right to marry extends to same-sex couples.”
But in the DOMA brief, the group notes that three states voted in favor of marriage equality and Minnesota rejected an anti-gay marriage amendment to argue gay people aren’t a “politically powerless” group that need protection from discrimination.
“So when voters reject gay rights at the ballot box, they are reflecting public opinion,” concludes Right Wing Watch blogger Miranda Blue. “But when they vote in favor of gay rights, they have been ‘enlisted’ to the cause by powerful gay rights lobbyists.”
William Duncan, director of the Marriage Law Foundation, filed a brief on behalf of the National Organization for Marriage in the DOMA case, but identifies himself as a “scholar of history and related disciplines” in the Prop 8 case.
“When the People of California adopted Proposition 8, they acted to retain in their law an understanding of marriage that, until very recently, was recognized universally and without exception throughout time and across cultures,” Duncan said. “That conception of the institution of marriage has consistently been understood to advance crucial social interests in procreation, understood as the bearing and rearing of children.”
Duncan cites in his arguments a series of philosophers who’ve had an impact on American thinking, including Noah Webster and David Hume. The brief also cites a 1690 piece of writing from British philosopher John Locke, who said marriage “has no necessary form or function beyond this ‘chief end’ of procreation.”
Another brief in the Prop 8 case was filed by a coalition of black pastors, including the Coalition of African-American Pastors USA and the Frederick Douglass Foundation. That brief argues at length that the 1967 Supreme Court ruling in Loving v. Virginia striking down bans on interracial marriage shouldn’t be applied to gay couples.
“Loving can be distinguished from the current dispute over same-sex marriage,” the brief states. “Laws against miscegenation were designed to segregate the races, reinforcing the socially disadvantaged position of African-Americans. … By contrast, the traditional definition of marriage calls for mixing of the genders — integration not segregation — and therefore cannot be understood as an attempt to disadvantage either gender.”
During a news conference in September, Rev. William Owens, founder and president of the Coalition of African-American Pastors, admitted that he has limited financial ties to NOM. Owens said the group provides him and his wife a salary of $20,000 a year.
Notably, the brief isn’t signed by black pastors. The attorneys who signed the brief are Lynn Wardle, a law professor at Brigham Young University, and Stephen Kent Ehat, an attorney who does business as the Utah-based California Research Inc., and is a graduate of BYU law school.
Yet another brief was filed by three gay individuals who believe same-sex couples shouldn’t have the right to marry. They are David Benkof, ex-owner of the gay press syndicate Q Syndicate and now a resident of Israel; Robert Oscar Lopez, a bisexual award-winning writer who’s written comedies about same-sex couples raising children; and Doug Mainwaring, a gay writer who rethought the capability of same-sex unions to raise children after realizing the importance to his teenage sons of their mother’s presence in their lives. The brief is signed by Herbert Grey, a private attorney based in Beaverton, Ore.
“We, and they, believe gay people should be free to love and live as they choose but we also recognize that society has a right to express a rational preference for the kind of unions necessary to the survival of the whole society, and to the well-being of children,” the brief states. “Some gay, lesbian and bisexual people will benefit from this preference as they may marry a person of the opposite-sex.”
The brief by the Westboro Baptist Church, a virulently anti-gay Kansas-based organization known for picketing the funerals of service members with signs reading, “God Hates Fags,” makes arguments characteristic of its organization in briefs both for the Prop 8 case and DOMA case.
Members of the Westboro Baptist Church. (Washington Blade file photo by Michael Key)
“This nation has gone astray, letting fornication, adultery, abortion-for-convenience-on-demand, divorce, remarriage and sodomy become the norm,” the church says in its DOMA brief. “Homosexuality is destructive in every way, to the individual and to the nation. Government should not put its seal of approval on that unholy union by issuing a marriage license. Government’s interest is in doing the opposite, for the good of the people and the nation.”
The brief is signed by Margie Phelps, daughter of church founder Fred Phelps, who has represented the church in a lawsuit against it before the Supreme Court.
Mary Bonauto, civil rights director for Gay & Lesbian Advocates & Defenders, said the “anti-gay machine is alive and well,” but noted that each of the briefs takes a different approach to supporting Prop 8 and DOMA.
“As you would expect, some of the briefs were based a particular religious view,” Bonauto said. “Others claimed they were secular but simply reasoned based on certain religious principles. Others raised the religious freedom argument that it is a burden for objecting members of the public to have to deal with the existence of married gay people.”
Bonauto added, “Overall, none of these briefs raise a new issue and several are helpful to us.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Reasons to be optimistic about 2026
Long-awaited ‘Pillion’ surpasses the sexy buzz
Protecting the trans community is not optional for elected allies and candidates
Trump’s ‘American people derangement syndrome’
